Studies in cervical cancer demonstrate that LSD1 knockdown reduces CD47 and PD-L1 protein expression, with ChIP-Seq analyses revealing elevated H3K4me2 levels at the CD47 and PD-L1 promoter regions following LSD1 inhibition, indicating direct epigenetic regulation. Here, CD47 is linked to cervical cancer.